Dramatically improved cancer-specific outcomes were found in patients with early-stage non–small cell lung cancer (NSCLC) who, after their surgery, ad...

Opinion Video Author(s): Panelists discuss how deuruxolitinib, evaluated in the THRIVE-AA1 and THRIVE-AA2 phase 3 trials, differs from previous Janus...

Protein and RNA analysis can shed light on infection risk among people with chronic lymphocytic leukemia (CLL) receiving immune-based therapies, accor...

Workforce challenges across cardiology, and electrophysiology in particular, are intensifying at a time when the burden of arrhythmias is expected to...

At a recent Institute for Value-Based Medicine® event, Joanne Mortimer, MD, FACP, FASCO, medical oncologist at City of Hope in Los Angeles, California...

When evaluating a patient presenting with symptoms suggestive of arrhythmia, the initial diagnostic approach heavily depends on several factors includ...

Kristen R. Choi, Associate Professor & Audrienne H. Moseley Chair in Nursing at UCLA Joe C. Wen School of Nursing & UCLA Fielding School of Public Hea...

New research suggests that NOTCH1 expression levels play an important role in response to treatment in patients with small cell lung cancer (SCLC).1 T...

The FDA has approved the biologics license application for lecanemab-irmb (Leqembi Iqlik; Eisai), the first and only anti-amyloid therapy to provide a...

Why is health care so staggeringly difficult to use? How do we fix it? To move forward, we first must look back, because the system we have today was...